|

Lomustine Clinical Trials

10 actively recruiting trials across 7 locations

Also known as: 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-, Belustin, Belustine, CCNU +14 more

Pipeline

Phase 1: 1Phase 2: 3Phase 3: 2Phase 1/2: 2Phase 2/3: 1

Top Sponsors

  • Philogen S.p.A.2
  • VBI Vaccines Inc.1
  • University of California, Davis1
  • The University of Texas Health Science Center at San Antonio1
  • National Cancer Institute (NCI)1

Indications

  • Cancer10
  • Glioblastoma6
  • Recurrent Glioblastoma2
  • Glioblastoma Multiforme2
  • Astrocytoma of Brain1

Other2 trials

A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Phase 1/2
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Phase 3

Birmingham, Alabama2 trials

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Hospital of Alabama

Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

University of Alabama at Birmingham

Phase 2/3

Jonesboro, Arkansas1 trial

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

Phase 2

Irvine, California1 trial

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

University of California, Irvine

Phase 1/2

Sacramento, California1 trial

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

University of California Davis Comprehensive Cancer Center

Phase 1

San Francisco, California1 trial

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

University of California, San Francisco

Chicago, Illinois1 trial

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

Northwestern Memorial Hospital

Phase 2

San Antonio, Texas1 trial

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Mays Cancer Center, UT Health San Antonio

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.